Ocular drug targeting is one of the most interesting and challenging research
topics due to the presence of natural barriers of the eye that attract pharmaceutical
technologists. It is important to treat ocular infections, which are frequently
encountered and affect people of all ages, in order to protect the integrity of the eye.
For this reason, anti-infective agents used in the treatment of ocular infections are
frequently the subject of ocular drug delivery system studies. The ocular bioavailability
of anti-infective agents is also increased, thanks to micro and nano-carriers, where the
dose strength of drugs and frequency of administration can be reduced. On the other
hand, the fact that there are products approved by the USFDA among these delivery
systems which have completed clinical phase studies shows that these drug delivery
systems are promising in the ocular field.
Keywords: Anti-infective agents, Ocular drugs, Ocular drug delivery systems,
Nanotechnology, Ocular anatomy, Ocular physiology, Pharmacokinetic.
